Business Description
Australian Clinical Labs Ltd
ISIN : AU0000148496
Description
Australian Clinical Labs, or ACL, is Australia's third-largest private pathology provider. ACL earns almost its entire group revenue from pathology services in Australia, which are mostly earned via the publicly funded health Medicare system. ACL is well-established in the states of Western Australia, South Australia, Victoria and the Northern Territory.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.08 | |||||
| Equity-to-Asset | 0.28 | |||||
| Debt-to-Equity | 1.98 | |||||
| Debt-to-EBITDA | 2.13 | |||||
| Interest Coverage | 7.33 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 2.42 | |||||
| Beneish M-Score | -3.66 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Book Growth Rate | 54.2 | |||||
| Future 3-5Y Total Revenue Growth Rate | 2.56 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 62.59 | |||||
| 9-Day RSI | 48.5 | |||||
| 14-Day RSI | 44.03 | |||||
| 6-1 Month Momentum % | -5.34 | |||||
| 12-1 Month Momentum % | -27.12 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.66 | |||||
| Quick Ratio | 0.57 | |||||
| Cash Ratio | 0.13 | |||||
| Days Inventory | 47.72 | |||||
| Days Sales Outstanding | 37.85 | |||||
| Days Payable | 95.83 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 4.02 | |||||
| Dividend Payout Ratio | 1.56 | |||||
| Forward Dividend Yield % | 4.02 | |||||
| 5-Year Yield-on-Cost % | 4.1 | |||||
| 3-Year Average Share Buyback Ratio | 0.1 | |||||
| Shareholder Yield % | -1.83 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 81 | |||||
| Operating Margin % | 5.32 | |||||
| Net Margin % | 2.33 | |||||
| FCF Margin % | 22.13 | |||||
| ROE % | 9.04 | |||||
| ROA % | 2.63 | |||||
| ROIC % | 3.85 | |||||
| ROC (Joel Greenblatt) % | 9.42 | |||||
| ROCE % | 7.11 | |||||
| Years of Profitability over Past 10-Year | 3 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 32.34 | |||||
| Forward PE Ratio | 13.19 | |||||
| PE Ratio without NRI | 27.66 | |||||
| PS Ratio | 0.76 | |||||
| PB Ratio | 3.03 | |||||
| Price-to-Free-Cash-Flow | 3.41 | |||||
| Price-to-Operating-Cash-Flow | 3.26 | |||||
| EV-to-EBIT | 28.56 | |||||
| EV-to-Forward-EBIT | 10.24 | |||||
| EV-to-EBITDA | 5.24 | |||||
| EV-to-Forward-EBITDA | 4.06 | |||||
| EV-to-Revenue | 1.22 | |||||
| EV-to-Forward-Revenue | 1.13 | |||||
| EV-to-FCF | 5.32 | |||||
| Earnings Yield (Greenblatt) % | 3.5 | |||||
| FCF Yield % | 29.21 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Australian Clinical Labs Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | 663.423 | ||
| EPS (TTM) (A$) | 0.077 | ||
| Beta | 0 | ||
| Volatility % | 33.22 | ||
| 14-Day RSI | 44.03 | ||
| 14-Day ATR (A$) | 0.064466 | ||
| 20-Day SMA (A$) | 2.5415 | ||
| 12-1 Month Momentum % | -27.12 | ||
| 52-Week Range (A$) | 2.26 - 3.69 | ||
| Shares Outstanding (Mil) | 201.83 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Australian Clinical Labs Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Australian Clinical Labs Ltd Stock Events
| Event | Date | Price(A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Australian Clinical Labs Ltd Frequently Asked Questions
What is Australian Clinical Labs Ltd(ASX:ACL)'s stock price today?
The current price of ASX:ACL is A$2.49. The 52 week high of ASX:ACL is A$3.69 and 52 week low is A$2.26.
When is next earnings date of Australian Clinical Labs Ltd(ASX:ACL)?
The next earnings date of Australian Clinical Labs Ltd(ASX:ACL) is 2024-08-22 Est..
Does Australian Clinical Labs Ltd(ASX:ACL) pay dividends? If so, how much?
The Dividend Yield %  of Australian Clinical Labs Ltd(ASX:ACL) is 4.02% (As of Today), Highest Dividend Payout Ratio of Australian Clinical Labs Ltd(ASX:ACL) was 2.68. The lowest was 0.14. And the median was 1.41. The  Forward Dividend Yield % of Australian Clinical Labs Ltd(ASX:ACL) is 4.02%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers